MACPAC Works On Recommendation To Let States Limit Drug Coverage

Congress’ Medicaid payment advisers are one meeting closer to deciding whether to recommend that Congress should give states flexibility to restrict coverage of doctor-administered drugs that are subject to national coverage policies under Medicare. The Medicaid and CHIP Payment and Access Commission debated the draft recommendation at its December meeting Thursday (Dec. 8). The proposal was initially created in light of Medicare’s decision to restrict coverage of the costly Alzheimer's drug Aduhelm, and similar future treatments by other companies, to...